Renal Cancer

March 1, 2019

National Kidney Cancer Awareness Month on CancerConnect

Charles H. Weaver, MD
February 8, 2019

First-Line Inlyta Active in Metastatic Kidney Cancer

Charles H. Weaver, MD
February 8, 2019

Study of Opdivo® vs Afinitor® Stopped when Opdivo Demonstrated Better Survival

Charles H. Weaver, MD
February 8, 2019

Inlyta Approved for Advanced Kidney Cancer

Charles H. Weaver, MD
February 8, 2019

Votrient Improves Progression-free Survival in Advanced Kidney Cancer

Charles H. Weaver, MD
February 8, 2019

Interleukine 2 Can Achieve Long-Term Survival in Renal Cell Cancer

Charles H. Weaver, MD
February 8, 2019

Updated Results Confirm Survival Benefit of Nexavar® in Renal Cell Carcinoma

Charles H. Weaver, MD
February 8, 2019

Experts Discuss What you Need to Know About Kidney (Renal Cell) Cancer

Charles H. Weaver, MD
February 7, 2019

Radiofrequency Ablation Effective For Small Kidney Cancers

Charles H. Weaver, MD
February 7, 2019

Comparison of Partial Nephrectomy with Radical Nephrectomy in Renal Cancer

Charles H. Weaver, MD
February 7, 2019

Mortality from Some Cancer Surgeries Reduced in Large-Volume Hospitals

Charles H. Weaver, MD
February 5, 2019

The CancerConnect Renal Cancer Newsletter

Charles H. Weaver, MD